$74.92
0.660.89%
At Close: -
$75.10
0.180.24%
After Hours: 5:53 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Boston Scientific (NYSE:BSX) Stock, Analyst Ratings, Price Targets, Forecasts
Boston Scientific Corp has a consensus price target of $81.83 based on the ratings of 24 analysts. The high is $95 issued by Argus Research on May 28, 2024. The low is $58 issued by Morgan Stanley on April 27, 2023. The 3 most-recent analyst ratings were released by Raymond James, Deutsche Bank, and RBC Capital on July 25, 2024, respectively. With an average price target of $84.67 between Raymond James, Deutsche Bank, and RBC Capital, there's an implied 12.74% upside for Boston Scientific Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Deutsche Bank
RBC Capital
JP Morgan
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Boston Scientific
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/25/2024 | Buy Now | 21.17% | Raymond James | Jayson Bedford | $85 → $91 | Maintains | Strong Buy | Get Alert |
| 07/25/2024 | Buy Now | 3.86% | Deutsche Bank | Pito Chickering | $73 → $78 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 13.18% | RBC Capital | Shagun Singh | $82 → $82 | Reiterates | Outperform → Outperform | Get Alert |
| 07/25/2024 | Buy Now | 13.18% | JP Morgan | Robbie Marcus | $82 → $85 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | 17.18% | Canaccord Genuity | William Plovanic | $83 → $88 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 21.17% | Baird | David Rescott | $90 → $91 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 14.51% | Needham | Mike Matson | $82 → $86 | Maintains | Buy | Get Alert |
| 07/16/2024 | Buy Now | 14.51% | TD Cowen | Joshua Jennings | $77 → $86 | Maintains | Buy | Get Alert |
| 07/16/2024 | Buy Now | 19.84% | Truist Securities | Richard Newitter | $86 → $90 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 11.85% | BTIG | Marie Thibault | $80 → $84 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 22.5% | Morgan Stanley | Patrick Wood | $79 → $92 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 19.84% | Citigroup | Joanne Wuensch | $87 → $90 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 7.86% | Evercore ISI Group | Vijay Kumar | $78 → $81 | Maintains | Outperform | Get Alert |
| 06/18/2024 | Buy Now | 9.19% | Needham | Mike Matson | $82 → $82 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 19.84% | Goldman Sachs | David Roman | → $90 | Initiates | → Buy | Get Alert |
| 05/28/2024 | Buy Now | 26.5% | Argus Research | John Eade | $80 → $95 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 15.85% | Citigroup | Joanne Wuensch | $85 → $87 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 19.84% | Mizuho | Anthony Petrone | $85 → $90 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 3.86% | Barclays | Matt Miksic | $70 → $78 | Maintains | Overweight | Get Alert |
| 04/25/2024 | Buy Now | 13.18% | Citigroup | Joanne Wuensch | $79 → $85 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | -2.8% | Deutsche Bank | Pito Chickering | $63 → $73 | Maintains | Hold | Get Alert |
| 04/25/2024 | Buy Now | 9.19% | JP Morgan | Robbie Marcus | $72 → $82 | Maintains | Overweight | Get Alert |
| 04/25/2024 | Buy Now | 13.18% | Raymond James | Jayson Bedford | $73 → $85 | Maintains | Strong Buy | Get Alert |
| 04/25/2024 | Buy Now | 9.19% | RBC Capital | Shagun Singh | $78 → $82 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | 13.18% | Mizuho | Anthony Petrone | $80 → $85 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | 19.84% | UBS | Danielle Antalffy | $74 → $90 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | 9.19% | Wells Fargo | Larry Biegelsen | $72 → $82 | Maintains | Overweight | Get Alert |
| 04/25/2024 | Buy Now | 3.86% | Evercore ISI Group | Vijay Kumar | $72 → $78 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | 11.85% | Baird | David Rescott | $79 → $84 | Maintains | Outperform | Get Alert |
| 04/24/2024 | Buy Now | 9.19% | Needham | Mike Matson | $71 → $82 | Maintains | Buy | Get Alert |
| 04/15/2024 | Buy Now | 3.86% | RBC Capital | Shagun Singh | $70 → $78 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | -4.13% | Evercore ISI Group | Vijay Kumar | $68 → $72 | Maintains | Outperform | Get Alert |
| 04/03/2024 | Buy Now | 6.52% | Argus Research | John Eade | $69 → $80 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 5.19% | Citigroup | Joanne Wuensch | $71 → $79 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 2.53% | TD Cowen | Joshua Jennings | $65 → $77 | Maintains | Outperform | Get Alert |
| 02/05/2024 | Buy Now | -6.79% | RBC Capital | Shagun Singh | → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 02/01/2024 | Buy Now | -5.46% | Citigroup | Joanne Wuensch | $65 → $71 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | -5.46% | Needham | Mike Matson | $60 → $71 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | -2.8% | Raymond James | Jayson Bedford | $67 → $73 | Maintains | Strong Buy | Get Alert |
| 02/01/2024 | Buy Now | -9.45% | Oppenheimer | Steven Lichtman | $58 → $68 | Maintains | Perform | Get Alert |
| 02/01/2024 | Buy Now | 6.52% | Mizuho | Anthony Petrone | → $80 | Upgrade | Neutral → Buy | Get Alert |
| 02/01/2024 | Buy Now | -6.79% | RBC Capital | Shagun Singh | $67 → $70 | Maintains | Outperform | Get Alert |
| 02/01/2024 | Buy Now | -4.13% | JP Morgan | Robbie Marcus | $60 → $72 | Maintains | Overweight | Get Alert |
| 02/01/2024 | Buy Now | -4.13% | Wells Fargo | Larry Biegelsen | $70 → $72 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | -10.79% | RBC Capital | Shagun Singh | → $67 | Reiterates | Outperform → Outperform | Get Alert |
| 01/03/2024 | Buy Now | -10.79% | Raymond James | Jayson Bedford | $61 → $67 | Maintains | Strong Buy | Get Alert |
| 12/29/2023 | Buy Now | -14.78% | BTIG | Marie Thibault | $64 → $64 | Reiterates | Buy → Buy | Get Alert |
| 12/29/2023 | Buy Now | -17.44% | Wells Fargo | Larry Biegelsen | $62 → $62 | Reiterates | Overweight → Overweight | Get Alert |
| 12/22/2023 | Buy Now | -12.12% | Truist Securities | Richard Newitter | $59 → $66 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | -17.44% | Wells Fargo | Larry Biegelsen | $59 → $62 | Maintains | Overweight | Get Alert |
| 12/12/2023 | Buy Now | -13.45% | TD Cowen | Joshua Jennings | $58 → $65 | Maintains | Outperform | Get Alert |
| 12/04/2023 | Buy Now | -18.77% | Morgan Stanley | Patrick Wood | $58 → $61 | Maintains | Overweight | Get Alert |
| 11/27/2023 | Buy Now | -14.78% | Canaccord Genuity | William Plovanic | $60 → $64 | Maintains | Buy | Get Alert |
| 10/27/2023 | Buy Now | -20.11% | Needham | Mike Matson | $65 → $60 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | -20.11% | Barclays | Matt Miksic | $59 → $60 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | -18.77% | Truist Securities | Richard Newitter | → $61 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | Buy Now | -16.11% | Baird | David Rescott | $60 → $63 | Maintains | Outperform | Get Alert |
| 09/21/2023 | Buy Now | -20.11% | Mizuho | Anthony Petrone | $56 → $60 | Maintains | Neutral | Get Alert |
| 09/21/2023 | Buy Now | -20.11% | Stifel | Rick Wise | $58 → $60 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -12.12% | UBS | Danielle Antalffy | $63 → $66 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -16.11% | Citigroup | Joanne Wuensch | $63 → $63 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | Buy Now | -14.78% | Canaccord Genuity | William Plovanic | $62 → $64 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -18.77% | RBC Capital | Shagun Singh | $58 → $61 | Maintains | Outperform | Get Alert |
| 09/21/2023 | Buy Now | -14.78% | BTIG | Marie Thibault | $62 → $64 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -13.45% | Needham | Mike Matson | $61 → $65 | Maintains | Buy | Get Alert |
| 09/20/2023 | Buy Now | -18.77% | Needham | Mike Matson | → $61 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | Buy Now | -20.11% | Evercore ISI Group | Vijay Kumar | → $60 | Maintains | Outperform | Get Alert |
| 09/11/2023 | Buy Now | -18.77% | Needham | Mike Matson | → $61 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | -25.43% | Mizuho | Anthony Petrone | → $56 | Reiterates | Neutral → Neutral | Get Alert |
| 08/28/2023 | Buy Now | -22.77% | RBC Capital | Shagun Singh | → $58 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2023 | Buy Now | -18.77% | Needham | Mike Matson | → $61 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | -16.11% | Citigroup | Joanne Wuensch | $63 → $63 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | -18.77% | Needham | Mike Matson | → $61 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | Buy Now | -21.44% | Barclays | Matt Miksic | $56 → $59 | Maintains | Overweight | Get Alert |
| 07/31/2023 | Buy Now | -21.44% | Barclays | Matt Miksic | $56 → $59 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | -17.44% | Canaccord Genuity | William Plovanic | $58 → $62 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | -18.77% | Raymond James | Jayson Bedford | $60 → $61 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | -21.44% | Oppenheimer | Steven Lichtman | $58 → $59 | Maintains | Perform | Get Alert |
| 07/28/2023 | Buy Now | -18.77% | Needham | Mike Matson | $57 → $61 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | -18.77% | Truist Securities | Richard Newitter | $60 → $61 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | -21.44% | Baird | David Rescott | → $59 | Initiates | → Outperform | Get Alert |
| 07/12/2023 | Buy Now | -22.77% | RBC Capital | Shagun Singh | $56 → $58 | Maintains | Outperform | Get Alert |
| 07/06/2023 | Buy Now | -17.44% | Piper Sandler | Matt O'Brien | $58 → $62 | Maintains | Overweight | Get Alert |
| 06/30/2023 | Buy Now | -14.78% | CL King | Kristen Stewart | → $64 | Initiates | → Buy | Get Alert |
| 06/22/2023 | Buy Now | -16.11% | Citigroup | Joanne Wuensch | $60 → $63 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | -22.77% | Morgan Stanley | Patrick Wood | → $58 | Assumes | → Overweight | Get Alert |
| 04/27/2023 | Buy Now | -22.77% | Stifel | Rick Wise | $52 → $58 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | -26.76% | Deutsche Bank | Pito Chickering | $45 → $55 | Maintains | Hold | Get Alert |
| 04/27/2023 | Buy Now | -25.43% | RBC Capital | Shagun Singh | $53 → $56 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | -22.77% | Morgan Stanley | Cecilia Furlong | $56 → $58 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | -22.77% | Canaccord Genuity | William Plovanic | $53 → $58 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | -25.43% | Barclays | Matt Miksic | $53 → $56 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | -24.1% | Needham | Mike Matson | $56 → $57 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -25.43% | Needham | Mike Matson | $53 → $56 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | -28.1% | BTIG | Marie Thibault | $53 → $54 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | -21.44% | Truist Securities | Richard Newitter | $54 → $59 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | -20.11% | Raymond James | Jayson Bedford | $56 → $60 | Maintains | Strong Buy | Get Alert |
| 04/03/2023 | Buy Now | -20.11% | Citigroup | Joanne Wuensch | $54 → $60 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | -24.1% | UBS | Danielle Antalffy | → $57 | Initiates | → Buy | Get Alert |
| 02/02/2023 | Buy Now | -26.76% | JP Morgan | Robbie Marcus | $48 → $55 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Boston Scientific (BSX) stock?
The latest price target for Boston Scientific (NYSE:BSX) was reported by Raymond James on July 25, 2024. The analyst firm set a price target for $91.00 expecting BSX to rise to within 12 months (a possible 21.17% upside). 79 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Boston Scientific (BSX)?
The latest analyst rating for Boston Scientific (NYSE:BSX) was provided by Raymond James, and Boston Scientific maintained their strong buy rating.
When was the last upgrade for Boston Scientific (BSX)?
The last upgrade for Boston Scientific Corp happened on February 1, 2024 when Mizuho raised their price target to $80. Mizuho previously had a neutral for Boston Scientific Corp.
When was the last downgrade for Boston Scientific (BSX)?
There is no last downgrade for Boston Scientific.
When is the next analyst rating going to be posted or updated for Boston Scientific (BSX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Boston Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Boston Scientific was filed on July 25, 2024 so you should expect the next rating to be made available sometime around July 25, 2025.
Is the Analyst Rating Boston Scientific (BSX) correct?
While ratings are subjective and will change, the latest Boston Scientific (BSX) rating was a maintained with a price target of $85.00 to $91.00. The current price Boston Scientific (BSX) is trading at is $75.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.